HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel Carrier-Free Nanodrug Enhances Photodynamic Effects by Blocking the Autophagy Pathway and Synergistically Triggers Immunogenic Cell Death for the Efficient Treatment of Breast Cancer.

Abstract
Photosensitizers have been widely used to cause intratumoral generation of reactive oxygen species (ROS) for cancer therapy, but they are easily disturbed by the autophagy pathway, a self-protective mechanism by mitigating oxidative damage. Hereby, we reported a simple and effective strategy to construct a carrier-free nanodrug, Ce6@CQ namely, based on the self-assembly of the photosensitizer chlorin e6 (Ce6) and the autophagy inhibitor chloroquine (CQ). Specifically, Ce6@CQ avoided the unexpected toxicity caused by the regular nanocarrier and also ameliorated its stability in different conditions. Light-activated Ce6 generated cytotoxic ROS and elicited part of the immunogenic cell death (ICD). Moreover, CQ induced autophagy dysfunction, which hindered self-healing in tumor cells and enhanced photodynamic therapy (PDT) to exert a more potent killing effect and more efficient ICD. Also, Ce6@CQ could effectively accumulate in the xenograft breast tumor site in a mouse model through the enhanced permeability and retention (EPR) effect, and the growth of breast tumors was effectively inhibited by Ce6@CQ with light. Such a carrier-free nanodrug provided a new strategy to improve the efficacy of PDT via the suppression of autophagy to digest ROS-induced toxic substances.
AuthorsLuoyijun Xie, Li Wang, Ling Li, Chutong Liu, Lihao Guo, Yingying Liao, Shuyi Zhou, Weiwei Wu, Yanhong Duo, Leilei Shi, Miaomiao Yuan
JournalACS applied materials & interfaces (ACS Appl Mater Interfaces) Vol. 16 Issue 5 Pg. 5683-5695 (Feb 07 2024) ISSN: 1944-8252 [Electronic] United States
PMID38261396 (Publication Type: Journal Article)
Chemical References
  • Reactive Oxygen Species
  • Photosensitizing Agents
  • Porphyrins
Topics
  • Animals
  • Mice
  • Humans
  • Female
  • Breast Neoplasms (drug therapy, pathology)
  • Photochemotherapy
  • Reactive Oxygen Species (metabolism)
  • Cell Line, Tumor
  • Immunogenic Cell Death
  • Photosensitizing Agents (pharmacology, therapeutic use)
  • Nanoparticles
  • Autophagy
  • Porphyrins (pharmacology, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: